AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 86 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.18 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 141 | -32.5% | 0.00% | – |
| Q3 2018 | $1,000 | – | 209 | +167.9% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 78 | -99.9% | 0.00% | -100.0% |
| Q1 2018 | $381,000 | +3.8% | 131,501 | 0.0% | 0.03% | -3.4% |
| Q4 2017 | $367,000 | +14.7% | 131,501 | +49.9% | 0.03% | 0.0% |
| Q3 2017 | $320,000 | +3455.6% | 87,709 | +2148.9% | 0.03% | +2800.0% |
| Q2 2017 | $9,000 | +800.0% | 3,900 | +290.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 1,000 | -37.5% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 1,600 | +33.3% | 0.00% | – |
| Q1 2014 | $2,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |